Readystate Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Readystate Asset Management's REGN Position: Q2 2026 in Review
Readystate Asset Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 530 shares worth $330K. The stake represents 0.01% of the portfolio and ranks #739 among its holdings. This is a return to the name: Readystate Asset Management previously reported a position in REGN as recently as Q3 2024.
Readystate Asset Management first reported a position in REGN in Q3 2024 and has held it in 2 quarters since. The position peaked at $5.76M in Q3 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Readystate Asset Management held 530 shares of Regeneron Pharmaceuticals worth $330K as of Q2 2026.
- Regeneron Pharmaceuticals was a new Readystate Asset Management position in Q2 2026.
- Regeneron Pharmaceuticals made up 0.01% of Readystate Asset Management's portfolio in Q2 2026, its #739 holding.
- Readystate Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 2 quarters since.
- Readystate Asset Management's Regeneron Pharmaceuticals position peaked at $5.76M in Q3 2024.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.